Results 91 to 100 of about 330,546 (163)

An Unusual Presentation of Moyamoya Disease in a Pediatric Patient. [PDF]

Cureus
Shahrour O, Al Zubaidi A, Al Kaabi S.
europepmc   +1 more source

SDMA as a marker and mediator in cerebrovascular disease. [PDF]

Clin Sci (Lond)
Riddell A, Flynn A, Bergugnat H, Dowsett LB, Miller AA.   +4 more
europepmc   +1 more source

Clinical practice guidelines on addressing cognitive impairment in treatable dementias.

Indian J Psychiatry
Siddiqui MA, Garg S, Tikka SK.
europepmc   +1 more source

Liquid Biopsy-Derived Tumor Biomarkers for Clinical Applications in Glioblastoma. [PDF]

Biomolecules
de Lima BP, Ferraz LS, Devalle S, Borges HL.   +3 more
europepmc   +1 more source

Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4⁺Foxp3⁺ Regulatory T Cell Immunosuppression. [PDF]

Int J Drug Discov Pharm
Shao Y, Yang WY, Nanayakkara G, Saaoud F, Ben Issa M, Xu K, Lu Y, Jiang X, Mohsin S, Wang H, Yang X.   +10 more
europepmc   +1 more source

The wide phenotypic spectrum of thiamine metabolism dysfunction syndrome 5 and its treatment. [PDF]

Orphanet J Rare Dis
Dallan A, Reynolds G, Canavese C, Carli D, Luca M, Gazzin A, Spada M, Porta F, Mussa A.   +8 more
europepmc   +1 more source

Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson's and Alzheimer's Disease. [PDF]

Pharmaceuticals (Basel)
Blebea NM, Pușcașu C, Hancu G, Stăniguț AM, Chiriță C.   +4 more
europepmc   +1 more source

The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders. [PDF]

Ther Adv Neurol Disord
Si J, Yu K, Hao J, Wang J, Zhang L.
europepmc   +1 more source

The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity? [PDF]

Pituitary
Sola D, Lower Daniele MSB, Danesi L, D'Angelo E, Mirra N, Graziadei G, Cassinerio E, Pasquali R, Scacchi M.   +8 more
europepmc   +1 more source